Longa duração de epilepsia e envolvimento de múltiplos lobos são fatores preditivos de pior controle das crises convulsivas em pacientes com epilepsia refratária do lobo temporal associada a neurocisticercose by Meguins, Lucas Crociati et al.
1014
DOI: 10.1590/0004-282X20150175
ARTICLE
Longer epilepsy duration and multiple lobe 
involvement predict worse seizure outcomes 
for patients with refractory temporal lobe 
epilepsy associated with neurocysticercosis
Longa duração de epilepsia e envolvimento de múltiplos lobos são fatores preditivos 
de pior controle das crises convulsivas em pacientes com epilepsia refratária do lobo 
temporal associada a neurocisticercose
Lucas Crociati Meguins1, Rodrigo Antônio Rocha da Cruz Adry1, Sebastião Carlos da Silva Júnior1, Carlos 
Umberto Pereira2, Jean Gonçalves de Oliveira3,4, Dionei Freitas de Morais1, Gerardo Maria de Araújo Filho5, 
Lúcia Helena Neves Marques6
Neurocysticercosis (NCC) is an infection of the central 
nervous system in which the meninges are infected with 
the larval stage of the pork tapeworm  Taenia solium1,2,3. 
This tapeworm is endemic in the majority of low-income 
countries in which pigs are raised and continues to be one 
of the most important causes of seizures in the world4,5,6. The 
World Health Organization (WHO) lists NCC as a neglected 
tropical disease and estimates that approximately 50 million 
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AbstrAct
Objective: To investigate the surgical outcomes of temporal lobe epilepsy associated with hippocampal sclerosis (TLE-HS) and 
neurocysticercosis (NCC). Methods: A retrospective investigation of patients with TLE-HS was conducted in a tertiary center. Results: 
Seventy-nine (62.2%), 37 (29.1%), 6 (4.7%), and 5 (3.9%) patients were Engel class I, II, III, and IV, respectively. Fifty-two (71.2%) patients with 
epilepsy durations ≤  10 years prior to surgery were seizure-free 1 year after the operation compared to 27 (50.0%) patients with epilepsy 
durations > 10 years (p = 0.0121). Forty-three (72.9%) patients with three or fewer lobes affected by NCC were seizure-free one year after 
the operation, and 36 (52.9%) patients with more than three involved lobes were seizure-free after surgery (p = 0.0163). Conclusions: 
Longer epilepsy durations and multiple lobe involvement predicted worse seizure outcomes in TLE-HS plus NCC patients.
Keywords: temporal lobe epilepsy, hippocampal sclerosis, neurocysticercosis.
resumo
Objetivo: Investigar o resultado cirúrgico da epilepsia do lobo temporal associada à esclerose hipocampal (TLE-HS) e neurocisticercose 
(NCC). Métodos: Estudo retrospectivo realizado em um centro de epilepsia. Resultados: Cinqüenta e dois pacientes (71,2%) com 10 anos 
ou menos de epilepsia antes da cirurgia tornaram-se livres de crises após um ano da operação, enquanto que 27 (50,0%) com mais de dez 
anos tornaram-se livres de crises após a cirurgia (p = 0,0121). Quarenta e três pacientes (72,9%), com três ou menos lobos afetados pela 
NCC tornaram-se livres de crises após um ano de operação, enquanto que 36 pacientes (52,9%) com mais de três lobos envolvidos estavam 
livres de crises após a cirurgia (p = 0,0163). Conclusão: A duração mais longa da epilepsia e o envolvimento de múltiplos lobos prevê pior 
resultado após a cirurgia para TLE-HS mais NCC.
Palavras-chave: epilepsia do lobo temporal, esclerose hipocampal, neurocisticercose.
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people worldwide have NCC and that it causes approximate-
ly 50,000 deaths each year7. Recent Brazilian investigations 
have reported that NCC seems to contribute or even cause 
refractory epileptic seizures associated with hippocampal 
sclerosis8,9. According to these investigations, inflammatory 
and/or electrogenic mechanisms promoted by NCC may in-
duce epileptogenic discharges9.
In the present study, we investigated the surgical out-
comes of patients with temporal lobe epilepsy associated 
with hippocampal sclerosis and NCC.
metHoDs
study delineation
A retrospective observational investigation was conduct-
ed with data collected from all patients treated in the epilepsy 
clinic of the Faculdade de Medicina de Sao Jose do Rio Preto 
(FAMERP, a Brazilian tertiary referral epilepsy center) with di-
agnoses of temporal lobe epilepsy associated with hippocam-
pal sclerosis (TLE-HS) from January 2000 to March 2013. The 
clinical data were retrospectively obtained from the patient 
records and files. For all patients with a diagnosis of TLE-HS 
based on magnetic resonance imaging (MRI), the following 
data were collected: sex, age at surgery, handedness, type and 
number of antiepileptic drugs (AEDs) used, and formal neu-
ropsychological evaluation results. NCC was evaluated with 
brain computed tomography (CT). The present study was ap-
proved by the ethical committee of our institution.
Pre-surgical evaluation
The patients were submitted to video-electroencephalog-
raphy (EEG) monitoring using Neuro Workbench software 
and Nihon Kohden hardware to record all epileptic events 
for later evaluation. Patient data were analyzed by an ex-
perienced epileptologist as an integral part of the inpatient 
assessment.
All patients submitted to pre- and post-surgical (at 12 
months) neuropsychological assessments. Verbal memory 
was assessed with a list-learning task, and figural memo-
ry was assessed with a learning test involving independent 
items. Memory deficits were defined by performances that 
were one standard deviation below the normal performance 
of age-matched controls.
Brain MRI was performed obtained according to a spe-
cific epilepsy protocol using a Philips  1.5-Tesla scanner at 
the Department of Neuroradiology of our institution. All MRI 
data were analyzed by an experienced neuroradiologist who 
confirmed the visual radiological diagnoses of TLE-HS. NCC 
was evaluated with brain CT, and the number of involved 
lobes was documented. All patients underwent MRI within 
30 days of surgery and at each year of follow-up.
Biopsy specimens were collected from all patients with 
chronic drug-resistant TLE-HS with radiological evidence 
who underwent surgery. Standardized neuropathological 
analyses were performed for all studied patients. The surgical 
specimens submitted for neuropathological evaluation were 
microscopically analyzed using hematoxylin-eosin staining. 
The pathologists reported their findings blind to the clinical 
and imaging data.
surgical technique
The surgical approaches were similar for all patients, and 
a single neurosurgeon who was experienced with epilepsy 
surgery (SCS Jr.) performed all of the procedures. The patient 
positioning included the placement of a shoulder roll to el-
evate the trunk followed by turning of the head 15-20 degrees 
from the midline so that the operative side was facing up. 
The head was slightly extended to bring the sylvian fissure 
to a plane that was perpendicular to the operating approach. 
Finally, the vertex was dropped down toward the floor to im-
prove the surgeon’s access to the mesial structures and allow 
for less temporal lobe retraction. A reverse question mark in-
cision was made from immediately above the zygoma and 
extending back into the temporal region. An anterior tem-
poral craniotomy was performed respecting the anatomical 
landmarks of the temporal lobe from the root of the zygoma 
to the anatomic keyhole. The remaining anterior and lateral 
bone was removed by drilling down to the limits of the me-
dial fossa floor. At the end of the craniotomy, all of the bone 
edges were waxed as necessary, any exposed air cells were 
sealed, and take-up sutures were performed prior to opening 
the dura mater to prevent epidural bleeding. A maximum of 
4.0 to 5.0 cm of the anterior lateral temporal lobe was resect-
ed. The mesial resection included removal of the amygdala 
and the anterior 2.0 to 3.0 cm of the hippocampus.
outcome assessments and follow-up
Follow-up investigations were performed on the operat-
ed patients. At the 12-month follow-up, all patients under-
went a neurological examination that included observations 
of behavior disorders, explorations of seizure outcomes and 
1.5-Tesla cerebral MRI. Seizure outcomes were classified ac-
cording to the Engel classification.
ethical statement
The ethical committee of our institution analyzed the 
project and approved the investigation. This study complied 
with the Declaration of Helsinki. Informed consent was ac-
quired from all patients and/or guardians.
statistical analysis
The data collected from all patients were organized in ta-
bles. The data are expressed as the means ± the SDs for para-
metric variables and the median values for nonparametric vari-
ables. Statistical analyses were performed with Fisher’s exact 
tests. A p-value < 0.05 was considered statistically significant.
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resuLts
A total of 136 patients with medically intractable TLE-HS 
plus NCC were diagnosed and treated at our institution. 
However, nine patients were excluded from this sample be-
cause they did not achieve a minimum of 1 year of follow up.
Table 1 summarizes the clinical findings of 127 patients 
with TLE-HS plus NCC who underwent operations. There 
were more males than females, and the mean age at surgery 
was 34.7 ± 11.9 (21-68 years). The mean age at seizure onset 
was 14.4 ± 18.6 (8-65 years). The seizure frequency was 12.3 ± 
21.2 (1-90) per month. The mean time from seizure onset to 
surgery was 11.8 ± 22.9 (1-33 years). Complex partial seizures 
were the most common type and were present in 116 (91.3%) 
patients,  followed by generalized tonic-clonic seizures in 
9 (7.1%) patients and multiple seizure types in 2 (1.6%). 
Interictal EEG findings revealed that 97 (76.4%) patients pre-
sented with unilateral epileptic discharges, and 30 (23.6%) 
exhibited bilateral epileptic discharges. Based on neuropsy-
chological testing, the right hemisphere was the dominant 
side for memory in 5 (3.9%) patients, and the left hemisphere 
was dominant in 122 (96.1%). The mean long-term follow-up 
was 8.2 ± 5.8 (1-13 years).
Table 2 summarizes the surgical outcomes of the 127 pa-
tients with TLE-HS plus NCC who underwent surgery. After 
1 year of follow up, 79 (62.2%) patients were Engel class I, 
37 (29.1%) were Engel class II, 6 (4.7%) were Engel class III, 
and 5 (3.9%) were Engel class IV. Significant differences in 
the achievement of seizure freedom (Engel class I) were ob-
served according to the time from first seizure to surgery 
and the number of lobes affected by NCC. First, we found 
that 52 (71.2%) patients with epilepsy durations ≤ 10 years 
prior to surgery were seizure-free (Engel I) 1 year after the 
operation, whereas 27 patients (50.0%) with epilepsy dura-
tions > 10 years were seizure-free (Engel class I) following 
surgery (Fisher’s exact test, p = 0.0121). Second, we observed 
that 43 patients (72.9%) with three or fewer lobes affected by 
NCC were seizure-free (Engel class I) 1 year after the opera-
tion, and 36 patients (52.9%) with more than three involved 
lobes were seizure-free (Engel class I) (Fisher’s exact test, 
p = 0.0163). Neither the age at the time of surgery nor the side 
of the operation had a significant effect. No relationship be-
tween the side of the NCC and the side of the hippocampal 
sclerosis was observed in the present study.
Table 3 summarizes the complications that occurred in 
the 127 surgical patients. A total of 18 patients (14.2%) ex-
perienced post-operative complications. Infections were ob-
served in 14 (11.0%) patients, and 1 of these required bone 
removal. Two (1.6%) patients exhibited transitory contralat-
eral hemiparesis, and two (1.6%) had clinical complications 
Table 1. Clinical findings from 127 patients with TLE-HS plus 
NCC who underwent operations.
Number of cases/%
Sex
Female 59/46.5
Male 68/53.5
Mean age at surgery (years) 34.7 ± 11.9 (21-68 years)
Mean age at seizure onset (years) 14.4 ± 18.6 (8-65 years)
Seizure frequency/month 12.3 ± 21.2 (1-90)
Time from seizure onset to surgery (years) 11.8 ± 22.9 (1-33 years)
Seizure type
Partial complex 116/91.3
Tonic-clonic generalized 9/7.1
Multiple 2/1.6
EEG findings
Unilateral 97/76.4
Bilateral 30/23.6
Hemispheric dominance
Right 5/3.9
Left 122/96.1
Mean follow-up (years) 8.2 ± 5.8 (1-13 years)
EEG: electroencephalography; NCC: neurocysticercosis; TLE-HS: temporal 
lobe epilepsy associated with hippocampal sclerosis
Table 2. Seizure outcomes of 127 patients with TLE-HS plus NCC who underwent operations.
Engel Classification (n/%)
I II III IV 
Side of surgery
Right (79/62.2) 49/62.0 21/26.6 5/6.3 4/5.1
Left (48/37.8) 30/62.5 16/33.3 1/2.1 1/2.1
Time from first seizure*
≤ 10 years (73/57.5) 52/71.2 18/24.6 2/2.7 1/1.4
> 10 years (54/42.5) 27/50.0 19/35.2 4/7.4 4/7.4
Age at surgery
≤ 50 years (84/66.1) 53/63.1 25/29.8 4/4.8 3/3.6
> 50 years (43/33.9) 26/60.5 12/27.9 2/4.7 2/4.7
Involved lobes*
≤ 3 (59/46.5) 43/72.9 15/25.4 1/1.7 0/0.0
> 3 (68/53.5) 36/52.9 22/32.3 5/7.3 5/7.3
Total (n = 127) 79/62.2 37/29.1 6/4.7 5/3.9
NCC: neurocysticercosis TLE-HS: temporal lobe epilepsy associated with hippocampal sclerosis. *: Fisher’s exact test, p < 0.05 (Engle I)
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that consisted of mild renal insufficiency in one patient and a 
pulmonary embolus that was treated with anticoagulation in 
another. Both of these complications were resolved without 
further problems. There were no operative deaths.
DIscussIoN
NCC, an infection caused by the encysted larval stage of 
the tapeworm T. solium, constitutes one of the most com-
mon parasitic diseases of the nervous system in humans and 
is a major public health problem for most of the developing 
world10,11. The clinical manifestations of NCC are variable and 
strongly depend on the number, type, size, location, and stage 
of development of the cysticerci, as well as the immune re-
sponse of the host against the parasite12,13,14,15,16.
Seizures are the most frequent manifestations of NCC 
(70-90%) followed by headache (38%), focal deficits (16%), 
and signs of intracranial hypertension (ICH, 12%). Other 
manifestations occur in fewer than 10% of symptomatic pa-
tients13. Recent Brazilian investigations have reported that 
NCC seems to contribute to or even cause refractory epi-
leptic seizures associated with hippocampal sclerosis8,9. 
According to these investigations, the inflammatory and/or 
electrogenic effects elicited by NCC may induce epileptogen-
ic discharges9. In the present study, we presented our clini-
cal experience with refractory TLE-HS and NCC. Because the 
majority of our patients did not undergo a radiological inves-
tigation of the central nervous system to determine the pres-
ence of NCC prior to seizure onset, we cannot infer whether 
NCC precipitated the hippocampal scleroses; however, we 
believe that the presence of secondary epileptogenic zones 
induced by NCC may have accelerated degenerative process-
es already affecting the mesial structures.
Based on the increased prevalence of inactive NCC in pa-
tients with mesial temporal sclerosis (MTS) and refractory epi-
lepsy, a potential causal relationship between NCC and MTS has 
been proposed17. The authors of this proposal speculated that in-
flammatory lesions or repetitive seizures might play a role in dis-
ease pathogenesis17,18. Additionally, although refractory epilepsy 
associated with TLE-HS plus NCC was previously believed not 
to influence surgical outcomes19, these patients achieved post-
operative Engel IA statuses less frequently20. In the present study, 
we observed that a longer duration of epilepsy and the involve-
ment of multiple lobes predicted worse seizure outcomes in pa-
tients with HS plus NCC. Therefore, we propose that patients 
with HS plus NCC should be treated earlier in the natural course 
of the disease because once multiple sites of NCC are present 
and widely spread throughout the central nervous system, the 
seizure outcomes following surgery are worse. Bianchin et al.9 
also noted that single NCC lesions are more commonly identi-
fied ipsilateral to HS, and this finding is suggestive of an anatom-
ical relationship between TLE-HS and NCC.
There are several methodological aspects relevant to 
the present findings that should be interpreted in the con-
text of a number of limitations. First, this study was a non-
randomized retrospective investigation that was performed 
in a highly selected population of a tertiary epilepsy center. 
Secondly, these findings cannot be generalized to all patients 
with TLE-HS plus NCC because the results represent the 
surgical experience of a single institution. However, we de-
scribed the surgical outcomes of a relatively large number of 
patients who underwent surgery due to this pathology over 
an extended follow-up duration.
coNcLusIoNs
The present study revealed that TLE-HS plus NCC is high-
ly prevalent in patients with refractory epilepsy and that lon-
ger epilepsy duration and the involvement of multiple lobes 
may predict worst seizure outcomes in this group of patients. 
Early diagnosis and treatment may improve the prognoses of 
patients with TLE-HS plus NCC.
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